Related Experiment Video
Updated: Aug 13, 2026

Utilizing the Antigen Capsid-Incorporation Strategy for the Development of Adenovirus Serotype 5-Vectored Vaccine Approaches
Published on: May 6, 2015
The development of a bivalent vaccine against diarrhoeal disease
1University of Adelaide, Department of Medicine, Royal Adelaide Hospital, Australia.
Abstract:
The live oral typhoid vaccine Salmonella typhi Ty2la has been successfully used as an effective public health tool for the control of typhoid fever. This paper reviews the progress of one vaccine development programme, which uses this organism as a carrier of the O-antigens of Vibrio cholerae. It is already known that antibodies directed against the O-antigens have been previously demonstrated in animals to be protective against subsequent challenge with virulent organisms. This paper reports that the hybrid orally administrable typhoid/cholera vaccines that have resulted through this programme are immunogenic in humans, and therefore this represents the first significant step towards the development of an effective bivalent typhoid/cholera oral vaccine.
Related Concept Videos
Cross-reactivity
Vaccinations
Bacterial Gastroenteritis
Cholera
Poliomyelitis
Respiratory Syncytial Virus Disease

